Autolomous Ltd, a developer of critical manufacturing management systems for advanced therapies, and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, have demonstrated how to implement digital technologies into advanced therapy manufacturing.